(Q43784209)

26 November 2017

title

Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University (English)

1 reference

26 November 2017

1 reference

Murtha AD

1

1 reference

26 November 2017

Rupnow BA

2

1 reference

26 November 2017

Hansosn J

3

1 reference

26 November 2017

Knox SJ

4

1 reference

26 November 2017

Hoppe R

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

International Journal of Radiation Oncology Biology Physics

26 November 2017

published in

1 reference

26 November 2017

volume

49

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

3-15

1 reference

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

The role of radiation therapy in the management of stage III follicular lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? Long-term experience at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

High-dose therapy and transplantation for low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900780-X

7 January 2021

10.1016/S0360-3016(00)00780-X

Identifiers

DOI

1 reference

26 November 2017

1 reference